Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs Jabil Inc (JBL) Price & Performance

AbCellera Biologics IncTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs Jabil Inc — how do they compare? AbCellera Biologics Inc trades at $9.18 (market cap $2.99B), while Jabil Inc trades at $362.37 (market cap $37.37B). The key difference: Jabil Inc is far larger — about 12.5× AbCellera Biologics Inc's market cap, and Jabil Inc pays a 0.09% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.

ABCLJBL
Market Cap
$2.99B$37.37B
Sector
HealthTechnology
52-Week High
$9.76$385.50
52-Week Low
$2.78$192.49
Enterprise Value
$2.58B$39.90B
Dividend Yield
0.09%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About Jabil Inc

Jabil is a global manufacturing solutions provider for industries including healthcare, automotive, and cloud. It offers comprehensive design, engineering, and supply chain management for complex electronic products.

Read more on JBL